- Bayer ( OTCPK:BAYZF ) ( OTCPK:BAYRY ) said on Wednesday that it is collaborating with Google Cloud for early drug discovery.
- The collaboration will use Tensor Processing Units (TPUs) from Google Cloud, a unit of Alphabet ( GOOG ) ( GOOGL ), to help accelerate and scale Bayer's quantum chemistry calculations.
- The German conglomerate said that the theory of quantum mechanics applied to computer-aided drug discovery enables the in-silico modeling of biological and chemical systems with high accuracy, and has the potential to help identify novel drug candidates.
- The objectives of the partnership are to accelerate and scale quantum chemistry calculations using TPUs and to show fully quantum mechanical modeling of protein-ligand interactions.
- The results will decide the scientific and economic viability of large-scale density functional theory calculations for practical applications, according to Bayer.
- "By combining Google Cloud’s computing power with Bayer’s leading expertise in drug discovery we intend to unleash the potential of large-scale quantum chemistry," said Marianne De Backer, head of Strategy, Business Development & Licensing/Open Innovation and member of the Executive Committee, Pharmaceuticals Division at Bayer.
For further details see:
Bayer, Google Cloud team up for early drug discovery